» Articles » PMID: 36797715

Use of CAM Among Cancer Patients : Results of a Regional Survey in Sweden

Overview
Publisher Biomed Central
Date 2023 Feb 16
PMID 36797715
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of complementary and alternative medicine (CAM) by patients is widespread. However, there is a lack of knowledge regarding the extent and details of patient CAM use in Sweden, especially in rural Sweden. The aim of this study was to estimate the extent and characteristics of CAM use among cancer patients in Region Gävleborg.

Methods: A total of 631 questionnaires were distributed to which 376 responses were registered, yielding a response rate of 59.6%. Questionnaires were distributed to oncology patients at their first visit for curative treatment at the Department of Oncology, Gävle Hospital. Palliative patients were recruited at their first visit and during enrollment in palliative outpatient care in their own homes. The characteristics of the respondents were presented with standard descriptive statistics. A multivariable logistic model was fitted to calculate odds ratios (ORs) and identify potential predictors (Age, Gender, Education, Diagnosis) of CAM use post-cancer diagnosis.

Results: 54% of all participants reported lifetime CAM use, 34% reported CAM use post-diagnosis. The most common CAM methods used after diagnosis are vitamins, health food preparations, herbal teas, prayer and dietary methods. The most common source of information reported is family and friends. Almost 70% of those who used CAM after their diagnosis stated that they did not discuss their use with healthcare professionals. Most patients reported that they would like some CAM modalities to be offered within conventional care regardless of their own CAM use.

Conclusions: The use of CAM is common among patients with cancer in the region of Gävleborg, and previous studies show a similar use in Sweden in general. Based on the widespread use of CAM and patient interest in discussing CAM use with healthcare professionals, greater attention and focus should be placed on creating a basis for this dialogue. If we, as healthcare professionals, are to emphasise our commitment to providing patient-centred care, we must acknowledge that patients use CAM and are seeking a dialogue about CAM use in their care.

Citing Articles

Growth of Renal Cancer Cell Lines Is Strongly Inhibited by Synergistic Activity of Low-Dosed Amygdalin and Sulforaphane.

Markowitsch S, Pham T, Rutz J, Chun F, Haferkamp A, Tsaur I Nutrients. 2024; 16(21).

PMID: 39519581 PMC: 11547972. DOI: 10.3390/nu16213750.


Source credibility: a necessary North Star in cancer care.

OReilly S, Dennehy K, Collins D BJC Rep. 2024; 2(1):56.

PMID: 39516644 PMC: 11523956. DOI: 10.1038/s44276-024-00075-5.


Correlates and patterns of using complementary health approaches among individuals with recent and longer-term cancer diagnoses: a US national cross-sectional study.

Romeiser J, Chen Z, Nanavati K, Williams A J Cancer Surviv. 2024; .

PMID: 39249689 DOI: 10.1007/s11764-024-01665-5.


Regional Perspectives on Complementary and Alternative Medicine: Results of a Regional Survey.

Kallman M, Bergstrom S, Holgersson G, Jaras J, Randen Engqvist R, Bergqvist M Complement Med Res. 2024; 31(6):497-505.

PMID: 39163846 PMC: 11633865. DOI: 10.1159/000540663.


Interdisciplinary Integrative Oncology Group-Based Program: Evaluation of Long-Term Effects on Resilience and Use of Complementary and Alternative Medicine in Patients With Cancer.

Von Reusner M, Martens B, Barthel S, Weiser A, Ziert Y, Steinmann D Integr Cancer Ther. 2024; 23():15347354241269931.

PMID: 39155547 PMC: 11331462. DOI: 10.1177/15347354241269931.


References
1.
Hok J, Tishelman C, Ploner A, Forss A, Falkenberg T . Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive "exceptional" experiences. BMC Complement Altern Med. 2008; 8:48. PMC: 2538498. DOI: 10.1186/1472-6882-8-48. View

2.
Lyman G, Greenlee H, Bohlke K, Bao T, DeMichele A, Deng G . Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018; 36(25):2647-2655. DOI: 10.1200/JCO.2018.79.2721. View

3.
Clairet A, Boiteux-Jurain M, Curtit E, Jeannin M, Gerard B, Nerich V . Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Med Oncol. 2019; 36(5):45. DOI: 10.1007/s12032-019-1267-z. View

4.
Engdal S, Steinsbekk A, Klepp O, Nilsen O . Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008; 16(7):763-9. DOI: 10.1007/s00520-007-0371-3. View

5.
Lettner S, Kessel K, Combs S . Complementary and alternative medicine in radiation oncology : Survey of patients' attitudes. Strahlenther Onkol. 2017; 193(5):419-425. DOI: 10.1007/s00066-017-1101-5. View